Sergey Avtushenko
Direktor/Vorstandsmitglied bei PHARMSYNTHEZ
Profil
Sergey Sergeevich Avtushenko is currently the Director at Pharmsynthez PJSC and the Director at SynBio LLC.
Previously, he worked as the Executive Director at H & H LLC from 2003 to 2007 and as a Member-Management Board at Pharmavit Holding.
Mr. Avtushenko completed his undergraduate degree at Pavlov First Saint Petersburg State Medical University.
Aktive Positionen von Sergey Avtushenko
| Unternehmen | Position | Beginn |
|---|---|---|
| PHARMSYNTHEZ | Direktor/Vorstandsmitglied | - |
SynBio LLC
 SynBio LLC Pharmaceuticals: MajorHealth Technology SynBio LLC engages in original research and introduction of conceptually new medicines. The firm’s medicines help treat diseases like liver disease, cardiovascular disease, acute leukemia, growth hormone deficiency and diabetes milletus. Its work is based on scientific developments and conducted in cutting edge laboratories. The company was founded in 2011 and is headquartered in Moscow, Russian Federation. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Sergey Avtushenko
| Unternehmen | Position | Ende |
|---|---|---|
| H & H LLC | Direktor/Vorstandsmitglied | 01.01.2007 |
| Pharmavit Holding | Corporate Officer/Principal | - |
Ausbildung von Sergey Avtushenko
| Pavlov First Saint Petersburg State Medical University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PHARMSYNTHEZ | Health Technology |
| Private Unternehmen | 3 |
|---|---|
| H & H LLC | |
| Pharmavit Holding | |
SynBio LLC
SynBio LLC Pharmaceuticals: MajorHealth Technology SynBio LLC engages in original research and introduction of conceptually new medicines. The firm’s medicines help treat diseases like liver disease, cardiovascular disease, acute leukemia, growth hormone deficiency and diabetes milletus. Its work is based on scientific developments and conducted in cutting edge laboratories. The company was founded in 2011 and is headquartered in Moscow, Russian Federation. | Health Technology |
